Rafael
Coveñas Rodríguez
Profesor Titular de Universidad
Instituto de Neurociencias de Castilla y León
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Neurociencias de Castilla y León (173)
2024
-
Editorial for the Special Issue “Current Research on Cancer Biology and Therapeutics”
International Journal of Molecular Sciences
-
Editorial: New drugs, approaches and strategies for multiple sclerosis treatment
Frontiers in Neuroscience
2023
-
Anatomy of hypothalamic and diencephalic nuclei involved in seasonal fertility regulation in ewes
Frontiers in Veterinary Science, Vol. 10
-
Association of Neurokinin-1 Receptor Signaling Pathways with Cancer
Current Medicinal Chemistry, Vol. 31
-
Combination Therapy of Chemotherapy or Radiotherapy and the Neurokinin-1 Receptor Antagonist Aprepitant: A New Antitumor Strategy?
Current Medicinal Chemistry, Vol. 30, Núm. 16, pp. 1798-1812
-
Involvement of the Opioid Peptide Family in Cancer Progression
Biomedicines, Vol. 11, Núm. 7
-
Involvement of the Orexinergic System in Cancer: Antitumor Strategies and Future Perspectives
Applied Sciences (Switzerland), Vol. 13, Núm. 13
-
Neuropeptide Y Peptide Family and Cancer: Antitumor Therapeutic Strategies
International Journal of Molecular Sciences, Vol. 24, Núm. 12
-
Neurotensin and Alcohol Use Disorders: Towards a Pharmacological Treatment
International Journal of Molecular Sciences, Vol. 24, Núm. 10
-
Peptidergic Systems and Cancer: Focus on Tachykinin and Calcitonin/Calcitonin Gene-Related Peptide Families
Cancers, Vol. 15, Núm. 6
-
Peptidergic Systems as Antitumor Targets: A Right Direction to Fight Cancer?
Cancers
-
The Repurposing of Non-Peptide Neurokinin-1 Receptor Antagonists as Antitumor Drugs: An Urgent Challenge for Aprepitant
International Journal of Molecular Sciences, Vol. 24, Núm. 21
2022
-
Involvement of the Substance P/Neurokinin-1 Receptor System in Cancer
Cancers
-
Involvement of the orexinergic system in feeding
Applied Sciences (Switzerland), Vol. 12, Núm. 1
-
Regulation of Homeostasis by Neuropeptide Y: Involvement in Food Intake
Current Medicinal Chemistry, Vol. 29, Núm. 23, pp. 4026-4049
-
The Galaninergic System: A Target for Cancer Treatment
Cancers, Vol. 14, Núm. 15
-
The Neurokinin-1 Receptor Is Essential for the Viability of Human Glioma Cells: A Possible Target for Treating Glioblastoma
BioMed research international, Vol. 2022, pp. 6291504
-
The Neurotensinergic System: A Target for Cancer Treatment
Current Medicinal Chemistry, Vol. 29, Núm. 18, pp. 3231-3260
-
Why Use Aprepitant Only as a Cough Suppressant in Lung Cancer When at Higher Doses it Could Also Exert an Antitumor Action?
Archivos de Bronconeumologia
2021
-
Biochemical mechanisms associating alcohol use disorders with cancers
Cancers, Vol. 13, Núm. 14